BMC pulmonary medicine
June 12, 2026
1 min readIP Score 10/10
Diagnostic value of EBUS-TBNA for intrathoracic tuberculous lymphadenitis: a retrospective cohort analysis stratified by anti-tuberculosis treatment duration.
Bai Z; Sun Z; Dong Y; Nie W; Zhao J; Liang Q
Abstract
BACKGROUND: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely adopted to diagnose intrathoracic lymphadenopathy, including tuberculous lymphadenitis (TBLA). However, the influence of anti-tuberculosis (anti-TB) treatment duration on its diagnostic yield remains unclear. METHODS: In this retrospective cohort study, 78patients with suspected intrathoracic TBLA who underwent EBUS-TBNA between June 2017 and January 2024 were included. Patients were categorized into four groups by prior anti-TB treatment duration. Composite diagnostic criteria incorporating histopathology, microbiology, and treatment response were used as the reference standard. Diagnostic performance across lymph node stations and modalities was analyzed. Safety outcomes were also evaluated. RESULTS: The overall diagnostic sensitivity of EBUS-TBNA based on composite criteria was 96.2%. Stratified analysis showed no statistically significant difference in diagnostic positivity among untreated (95.9%), 1-30 days (83.3%), 31-180 days (100%), and > 180 days (100%) groups (P = 0.42). Diagnostic yield was consistent across mediastinal, hilar, and combined lymph node stations (P = 0.289). Among diagnostic modalities, TB-DNA, histopathology TB-SPOT and sputum Xpert demonstrated high positivity rates. No major complications occurred; minor self-limited bleeding was observed in 15.4% of patients. CONCLUSION: EBUS-TBNA is a safe and effective diagnostic tool for intrathoracic TBLA, with consistent performance in both treatment-naïve and pretreated patients, regardless of anti-TB therapy duration.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.